ARTL CIK: 1621221

Artelo Biosciences, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−6.14
FY22:
−8.01
FY23:
−8.21
FY24:
−8.35
FY25:
−8.52
Change from FY21 to FY25
millions USD
FY21:
−3.44
FY22:
2.96
FY23:
3.51
FY24:
7.77
FY25:
−0.06
Change from FY21 to FY25
millions USD
FY21:
14.1
FY22:
0
FY23:
0.57
FY24:
0.11
FY25:
6.87
millions USD
FY21:
4.49
FY22:
−5.27
FY23:
−4.07
FY24:
−0.48
FY25:
−1.74

All amounts in millions USD Data source:SEC EDGAR